These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9075678)

  • 1. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
    Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
    J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.
    Chan CC; Lee FY; Wang SS; Chang FY; Lin HC; Lin HJ; Chu CJ; Wu SL; Tai CC; Lee SD
    Clin Sci (Lond); 1998 Apr; 94(4):367-71. PubMed ID: 9640342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
    Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
    Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic studies and esophageal morphometric analyses in portal hypertensive rats with left adrenal vein ligation.
    Lee FY; Wang SS; Tsai YT; Chang FY; Lin HC; Hou MC; Chu CJ; Wu SL; Tai CC; Lee SD
    Scand J Gastroenterol; 1997 Jul; 32(7):725-30. PubMed ID: 9246715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Tanoue K; Sugimachi K
    Scand J Gastroenterol; 2000 Oct; 35(10):1097-105. PubMed ID: 11099065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
    Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
    Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
    Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
    Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
    Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-course changes in gastric mucosal blood perfusion following portal vein constriction in rats.
    Casadevall M; Tabasco-Minguillan J; Panés J; Cirera I; Piqué JM; Terés J
    J Hepatol; 1995 Aug; 23(2):193-8. PubMed ID: 7499791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Wu SL; Chan CC; Tai CC; Lai IN; Lee SD
    J Hepatol; 1999 Jun; 30(6):1105-11. PubMed ID: 10406190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased gastric bicarbonate secretion in portal hypertensive anesthetized rats: role of prostaglandins and nitric oxide.
    Lamarque D; Dutreuil C; Dhumeaux D; Delchier JC
    Dig Dis Sci; 1997 Apr; 42(4):743-50. PubMed ID: 9125643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
    Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
    J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment.
    Panés J; Casadevall M; Fernández M; Piqué JM; Bosch J; Casamitjana R; Cirera I; Bombí JA; Terés J; Rodés J
    Hepatology; 1994 Nov; 20(5):1261-70. PubMed ID: 7927261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats.
    Lee SS; Sharkey KA
    Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of inducible nitric oxide synthase in gastric mucosa of rats with portal hypertension: correlation with gastric mucosal damage.
    Hsieh JS; Wang JY; Lin SR; Lian ST; Chen FM; Hsieh MC; Huang TJ
    J Surg Res; 2003 Nov; 115(1):24-32. PubMed ID: 14572769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
    Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
    J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
    J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
    Casadevall M; Piqué JM; Cirera I; Goldin E; Elizalde I; Panés J; Martínez-Cuesta MA; Bosch J; Terés J; Rodés J
    Gastroenterology; 1996 Apr; 110(4):1156-65. PubMed ID: 8613005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
    Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
    Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.